查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1941195

持续正压呼吸器市场 - 全球产业规模、份额、趋势、机会及预测（按产品类型、类型、最终用户、地区和竞争格局划分，2021-2031年）

Continuous Positive Airway Pressure, Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球持续性阳压呼吸器（CPAP）设备市场预计将从 2025 年的 52.4 亿美元成长到 2031 年的 78.7 亿美元，复合年增长率为 7.01%。

这些设备作为治疗性呼吸辅助装置，透过面罩持续输送加压空气，帮助阻塞型睡眠呼吸中止症中止症患者保持呼吸道畅通。该市场的成长主要受健康相关因素驱动，而非技术趋势，例如睡眠障碍的增加、人口老化以及肥胖率上升，这些因素都在推动呼吸治疗的需求。根据美国睡眠医学会估计，到2024年，美国约有3,000万成年人患有阻塞型睡眠呼吸中止症，这是一个庞大的患者群体，亟需此类医疗解决方案。

市场概览
预测期 2027-2031
市场规模：2025年 52.4亿美元
市场规模：2031年 78.7亿美元
复合年增长率：2026-2031年 7.01%
成长最快的细分市场 自动的
最大的市场 北美洲

儘管市场需求强劲，但市场扩张常常受到许多挑战的阻碍，包括患者依从性低和设备不耐受。身体不适和恐惧症常常导致治疗中断，限制了设备的长期使用和定期更换。诊断与治疗依从性之间的脱节对产生收入构成重大障碍。根据美国国家睡眠基金会预测，到2025年，约有31%的睡眠呼吸中止症成年患者将无法获得必要的治疗，这表明在实现持续的市场渗透和治疗成功方面仍存在诸多障碍。

市场驱动因素

设备设计和连接方面的技术进步正在从根本上改变全球持续性阳压呼吸器(CPAP) 设备市场，整合云端生态系统可提高患者依从性并实现远端监测。这些智慧解决方案有助于即时调整治疗方案和自动数据跟踪，显着降低传统断开式介面的高掉线率，同时简化医疗服务提供者的临床工作流程。根据 ResMed 于 2024 年 10 月发布的最终律师报告 (DEF 14A)，该公司报告称其拥有 2,600 万台可云连接设备，展现了其数位化应用的广泛规模。这项技术优势正在推动商业性业绩的成长，该公司于 2024 年 10 月发布的第一季财报显示，营收成长了 11%，证实了市场对先进治疗解决方案的强劲需求。

阻塞型睡眠呼吸中止症（OSA）盛行率的不断上升是推动长期成长的关键因素，尤其是在全球仍有相当一部分人未被确诊的情况下。儘管诊断途径的改善和宣传宣传活动的发展正逐步将潜在需求转化为实际用户，但人口结构的变化，例如人口老化和肥胖率上升，导致需要呼吸支持的患者数量持续增长。根据瑞思迈（ResMed）于2024年8月发布的2024年度报告，预计全球将有9.36亿人患有睡眠呼吸中止症，这代表着一个庞大的潜在患者群体，远超目前的患病率。随着公共卫生措施日益关注睡眠卫生，总盛行率与确诊患者之间的差距不断缩小，从而推动了呼吸器的持续普及。

市场挑战

患者依从性低和对设备的耐受性差是严重阻碍全球持续阳压呼吸器（CPAP）设备市场成长的挑战。儘管治疗效果高度依赖长期持续使用，但这些问题对市场扩张构成重大障碍，因为患者往往在确诊后不久就因身体不适、面罩漏气、恐惧症症等原因停止治疗。高停药率会减少面罩、软管和过滤器等必需耗材的经常性收入，对市场产生负面影响，而这些耗材是製造商的主要利润来源。

此外，患者治疗依从性差限制了有效用户群的成长，阻碍了引进週期，并降低了对替换设备的需求。确诊患者数量与严格遵守治疗方案的患者数量之间的脱节，造成了市场效率的显着低下。美国胸腔科协会报告称，到2024年，CPAP治疗的整体依从率将约为50%。这项数据表明，由于依从性问题，近一半的潜在耗材和替换设备市场损失殆尽，儘管该行业服务的患者数量庞大，却未能充分发挥其收入潜力。

市场趋势

持续性呼吸道正压通气（CPAP）疗法与消费级穿戴装置和智慧家庭平台的融合，透过分散诊断流程并将未确诊患者纳入治疗流程，推动了市场扩张。领先的科技公司正在将临床级睡眠呼吸中止症检测演算法整合到热门智慧型手錶中，使这些消费性电子产品转变为预筛检工具，无需复杂的检查室程序即可实现被动式、连续式的居家监测。这一趋势惠及了大规模未确诊患者，并鼓励他们进行医疗咨询。例如，三星电子在2024年2月的新闻稿中宣布，其Galaxy Watch的睡眠呼吸中止症功能已获得美国食品药物管理局（FDA）的全新医疗设备认证（De Novo），从而建立了一条直接面向消费者的管道，用于识别中度至重度阻塞型睡眠呼吸中止症。

同时，微接触式面罩设计的进步正在改变患者介面系统介面，有效降低了因恐惧症和身体不适导致的高治疗放弃率。製造商正逐步摒弃笨重的头戴式装置，转而采用超轻便、微接触式的鼻托和鼻枕，这些产品利用先进材料和自适应贴合技术，在不施加过大压力的情况下提升气密性。这种转变着重美观和舒适性，旨在提高使用者耐受性，维持长期依从性，并确保耗材的定期更换。费雪派克医疗保健公司（Fisher & Paykel Healthcare）也顺应了这一趋势，在其2024年5月发布的2024年度报告中，阻塞型睡眠呼吸中止症面罩的收入增长了21%，并将这一成功归功于其新型微接触式面罩平台在全球范围内的日益普及。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

5. 全球持续阳压呼吸器（CPAP）设备市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依产品类型（CPAP 面罩、CPAP 加湿器、CPAP 马达、其他）
    • 按类型（手动和自动）
    • 按最终使用者（医院/诊所、门诊护理中心、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

6. 北美持续阳压呼吸器（CPAP）设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲持续阳压呼吸器（CPAP）设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

8. 亚太地区持续阳压呼吸器（CPAP）设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

9. 中东和非洲持续阳压呼吸器（CPAP）设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

10. 南美洲持续阳压呼吸器（CPAP）设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球持续阳压呼吸器（CPAP）设备市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • ResMed Inc.
  • Koninklijke Philips NV
  • Fisher & Paykel Healthcare Limited
  • Drive DeVilbiss Healthcare, LLC
  • BMC Medical Co., Ltd.
  • 3B Medical, Inc.
  • Somnetics International, Inc.
  • Apex Medical Corporation
  • Medtronic plc
  • LOwenstein Medical SE & Co. KG

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 7465

The Global Continuous Positive Airway Pressure (CPAP) Devices Market is projected to expand from USD 5.24 Billion in 2025 to USD 7.87 Billion by 2031, registering a CAGR of 7.01%. These devices function as therapeutic respiratory aids, delivering a steady stream of pressurized air through a mask to maintain open airways for patients suffering from obstructive sleep apnea. The market is primarily propelled by health-related factors independent of technological trends, including the increasing prevalence of sleep disorders, an aging population, and rising obesity rates, all of which heighten the demand for respiratory interventions. According to the American Academy of Sleep Medicine, nearly 30 million adults in the United States were estimated to have obstructive sleep apnea in 2024, highlighting the substantial patient base necessitating these medical solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 5.24 Billion
Market Size 2031USD 7.87 Billion
CAGR 2026-20317.01%
Fastest Growing SegmentAutomatic
Largest MarketNorth America

Despite strong demand, market expansion is frequently hindered by significant challenges related to patient non-compliance and device intolerance. Physical discomfort or claustrophobia often leads individuals to discontinue therapy, which limits the long-term adoption and scheduled replacement of these units. This disparity between diagnosis and adherence poses a critical obstacle to revenue generation. According to the National Sleep Foundation, approximately 31 percent of adults diagnosed with sleep apnea in 2025 were not receiving the necessary treatment, indicating a persistent barrier to achieving sustained market penetration and therapeutic success.

Market Driver

Technological advancements in device design and connectivity are fundamentally transforming the Global Continuous Positive Airway Pressure (CPAP) Devices Market by integrating cloud-based ecosystems that improve patient adherence and enable remote monitoring. These smart solutions facilitate real-time therapy adjustments and automated data tracking, which significantly lowers the high drop-out rates associated with traditional, non-connected interfaces while streamlining clinical workflows for healthcare providers. According to ResMed's 'Definitive Proxy Statement (DEF 14A)' from October 2024, the company reported a network of 26 million cloud-connectable devices, illustrating the massive scale of digital adoption. This technological leverage drives commercial performance, as evidenced by ResMed's 'First Quarter 2025 Earnings Press Release' in October 2024, which noted an 11 percent increase in revenue, underscoring the strong demand for advanced therapeutic solutions.

The increasing prevalence of Obstructive Sleep Apnea (OSA) acts as a primary driver for long-term expansion, especially given that a large segment of the global population remains undiagnosed. Enhanced diagnostic accessibility and awareness campaigns are gradually converting this latent demand into active users, while demographic shifts such as aging populations and rising obesity rates create a continuous influx of patients needing respiratory support. According to ResMed's '2024 Annual Report' from August 2024, an estimated 936 million people globally live with sleep apnea, representing a massive addressable patient pool exceeding current penetration levels. As public health initiatives focus on sleep hygiene, the gap between the total prevalence and the diagnosed population continues to close, fueling sustained device adoption.

Market Challenge

Patient non-compliance and device intolerance represent the challenging factors that significantly impede the growth of the Global Continuous Positive Airway Pressure (CPAP) Devices Market. These issues create substantial barriers to expansion because therapeutic effectiveness depends heavily on consistent, long-term usage, yet patients often abandon treatment shortly after diagnosis due to physical discomfort, mask leaks, or claustrophobia. High rates of therapy discontinuation negatively impact the market by diminishing the recurring revenue streams derived from essential consumables, such as masks, hoses, and filters, which constitute a major source of ongoing profit for manufacturers.

Furthermore, the inability to retain patients on therapy restricts the growth of the active user base, stalling the adoption cycle and lowering the demand for replacement devices. The discrepancy between the number of diagnosed patients and those who strictly adhere to the treatment regimen results in significant market inefficiency. According to the American Thoracic Society, overall compliance rates for CPAP therapy were reported to be approximately 50 percent in 2024. This statistic indicates that nearly half of the potential market for consumables and replacement units is lost to adherence issues, preventing the industry from realizing its full revenue potential despite the existence of a large addressable patient population.

Market Trends

The convergence of CPAP therapy with consumer wearables and smart home platforms is driving market expansion by decentralizing diagnostic pathways and guiding undiagnosed patients into treatment pipelines. Tech giants are embedding clinical-grade sleep apnea detection algorithms into popular smartwatches, turning consumer gadgets into preliminary screening tools that bypass complex laboratory procedures and enable passive, longitudinal home monitoring. This trend addresses the large undiagnosed patient pool by triggering medical consultations, as seen when Samsung Electronics announced in a February 2024 press release that it received De Novo authorization from the U.S. Food and Drug Administration for the sleep apnea feature on its Galaxy Watch, establishing a direct consumer channel for identifying moderate to severe obstructive sleep apnea.

Simultaneously, advancements in minimal-contact mask designs are revolutionizing the patient interface landscape to combat high therapy termination rates resulting from claustrophobia and physical discomfort. Manufacturers are moving away from bulky headgear in favor of ultra-lightweight, minimal-contact nasal cradles and pillows that employ advanced materials and auto-adjusting fit technologies to improve seal integrity without applying aggressive pressure. This shift focuses on aesthetics and comfort to improve user tolerance and sustain long-term compliance, ensuring regular replacement of consumables. Validating this trend, Fisher & Paykel Healthcare reported a 21 percent growth in obstructive sleep apnea mask revenue in their 'Annual Report 2024' from May 2024, attributing this success to the strong global adoption of their new minimalist mask platforms.

Key Market Players

  • ResMed Inc.
  • Koninklijke Philips N.V.
  • Fisher & Paykel Healthcare Limited
  • Drive DeVilbiss Healthcare, LLC
  • BMC Medical Co., Ltd.
  • 3B Medical, Inc.
  • Somnetics International, Inc.
  • Apex Medical Corporation
  • Medtronic plc
  • LOwenstein Medical SE & Co. KG

Report Scope

In this report, the Global Continuous Positive Airway Pressure (CPAP) Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Continuous Positive Airway Pressure (CPAP) Devices Market, By Product Type

  • CPAP Masks
  • CPAP Humidifier
  • CPAP Motors
  • Others

Continuous Positive Airway Pressure (CPAP) Devices Market, By Type

  • Manual
  • Automatic

Continuous Positive Airway Pressure (CPAP) Devices Market, By End User

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Continuous Positive Airway Pressure (CPAP) Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Continuous Positive Airway Pressure (CPAP) Devices Market.

Available Customizations:

Global Continuous Positive Airway Pressure (CPAP) Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Continuous Positive Airway Pressure (CPAP) Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (CPAP Masks, CPAP Humidifier, CPAP Motors, Others)
    • 5.2.2. By Type (Manual v/s Automatic)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Continuous Positive Airway Pressure (CPAP) Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Type
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By End User

7. Europe Continuous Positive Airway Pressure (CPAP) Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Type
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By End User
    • 7.3.2. France Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By End User

8. Asia Pacific Continuous Positive Airway Pressure (CPAP) Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Type
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By End User
    • 8.3.2. India Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By End User

9. Middle East & Africa Continuous Positive Airway Pressure (CPAP) Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Type
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By End User

10. South America Continuous Positive Airway Pressure (CPAP) Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Type
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Continuous Positive Airway Pressure (CPAP) Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. ResMed Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Koninklijke Philips N.V.
  • 15.3. Fisher & Paykel Healthcare Limited
  • 15.4. Drive DeVilbiss Healthcare, LLC
  • 15.5. BMC Medical Co., Ltd.
  • 15.6. 3B Medical, Inc.
  • 15.7. Somnetics International, Inc.
  • 15.8. Apex Medical Corporation
  • 15.9. Medtronic plc
  • 15.10. LOwenstein Medical SE & Co. KG

16. Strategic Recommendations

17. About Us & Disclaimer